These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5686275)

  • 21. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    EVANS JS; BOSTWICK L; MENGEL GD
    Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140
    [No Abstract]   [Full Text] [Related]  

  • 22. Accumulation and metabolism of adenallene by murine leukemia L1210 cells.
    Kessel D; Zemlicka J
    Arch Biochem Biophys; 1994 Jan; 308(1):222-5. PubMed ID: 8311456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and cellular pharmacology of cytosine arabinoside.
    Kufe DW; Spriggs DR
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):34-48. PubMed ID: 3925560
    [No Abstract]   [Full Text] [Related]  

  • 24. Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
    Dollinger MR; Burchenal JH; Kreis W; Fox JJ
    Biochem Pharmacol; 1967 Apr; 16(4):689-706. PubMed ID: 6033789
    [No Abstract]   [Full Text] [Related]  

  • 25. Modulation of metabolism of cytosine arabinoside in L cells by antibody and complement.
    Shearer WT; Green CG; Mettes HJ
    Immunopharmacology; 1983 Oct; 6(3):203-14. PubMed ID: 6629738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes.
    Mayhew E; Rustum YM; Szoka F; Papahadjopoulos D
    Cancer Treat Rep; 1979; 63(11-12):1923-8. PubMed ID: 526925
    [No Abstract]   [Full Text] [Related]  

  • 27. [Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside].
    Bukhman VM; Lichinitser MR; Svet-Moldavskiĭ GIa; Mkheidze DM
    Biull Eksp Biol Med; 1978 Mar; 85(3):340-3. PubMed ID: 276385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced antitumor effect of cytosine arabinoside given in a schedule dictated by kinetic studies in vivo.
    Young RC; Goldberg D; Schein PS
    Biochem Pharmacol; 1973 Jan; 22(2):277-80. PubMed ID: 4763256
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S; Lehman C; Cadman E
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of oestradiol on nucleoside transport in rat uterus.
    Oliver JM
    Biochem J; 1971 Jan; 121(1):83-8. PubMed ID: 5116565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y).
    Chu MY; Fischer GA
    Biochem Pharmacol; 1968 May; 17(5):753-67. PubMed ID: 5689802
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective chemotherapy for advanced murine L 1210 leukemia by combination of 2' deoxycytidine and lethal doses of cytosine-arabinoside.
    Buchman VM; Svet-Maoldavsky GJ; Lichinitser MR; Mkheidze DM
    Biomedicine; 1977 Jul; 27(5):179-80. PubMed ID: 922116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial rate kinetics and evidence for duality of mediated transport of adenosine, related purine nucleosides, and nucleoside analogues in L1210 cells.
    Chello PL; Sirotnak FM; Dorick DM; Yang CH; Montgomery JA
    Cancer Res; 1983 Jan; 43(1):97-103. PubMed ID: 6847787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
    Ho DH; Frei E
    Clin Pharmacol Ther; 1971; 12(6):944-54. PubMed ID: 5289712
    [No Abstract]   [Full Text] [Related]  

  • 35. Uptake and binding of vincristine by murine leukemia cells.
    Bleyer WA; Frisby SA; Oliverio VT
    Biochem Pharmacol; 1975 Mar; 24(5):633-9. PubMed ID: 1168475
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
    Veselý J; Pískala A
    Neoplasma; 1986; 33(1):3-10. PubMed ID: 2421173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of prolonged-release derivative of cytosine arabinoside, cytosine arabinoside-agarose conjugate.
    Hashida M; Kojima T; Muranishi S; Sezaki H
    Gan; 1978 Dec; 69(6):839-43. PubMed ID: 750275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of the enzymatic deamination of cytosine arabinoside. II. Properties of the deaminase of human liver.
    Camiener GW
    Biochem Pharmacol; 1967 Sep; 16(9):1681-9. PubMed ID: 4964068
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel nucleoside transport inhibitors of natural origin.
    Zhen YS; Su J; Xue YC; Qi CQ; Hu JL
    Adv Exp Med Biol; 1994; 370():779-82. PubMed ID: 7661021
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of methotrexate and cytosine arabinoside on polyamine metabolism in a mouse L1210 leukemia.
    Russell DH
    Cancer Res; 1972 Nov; 32(11):2459-62. PubMed ID: 5082594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.